Webcast
For many high-growth European-based technology and life science entreprises, the United States is the most attractive country for expansion and/or later-stage fundraising. The U.S. offers the promise of massive commercial opportunities, cooperation partnerships and plentiful venture and growth capital. However, doing business and raising money in an unfamiliar, highly-competitive environment requires thoughtful advance planning and clinical execution.
In this facilitated presentation and Q&A to follow, we will discuss best practices for navigating the logistical aspects of launching and operating a business in America and setting and meeting expectations for U.S. later-stage funding.
We will cover a number of frequently asked questions, such as:
To help you formulate any questions about U.S. expansion, scaling, fundraising, and exiting, visit our U.S. Expansion and Fundraising FAQ and our U.S. Expansion & Resources Library.
Sophie Goldsztejn
sgoldsztejn@wsgr.comDaniel counsels UK and European tech and life sciences companies on U.S. expansion and fundraising.
Matthew J. Meyer is chief business advisor for life sciences at Wilson Sonsini Goodrich & Rosati. Based in San Francisco, Matthew leads the firm's life science business advisory practice—a newly formed, innovative resource aimed at providing start-up and emerging life sciences companies with business insights, capabilities, and strategies to help them thrive and address some of their most challenging issues.